The National Pharmaceutical Council (NPC) in a recent report found that out of seven value assessment frameworks, there was no “best” framework for determining a product’s value.
NPC Vice President for Health Services Research tells the Society for Women’s Health Research that there not being a top framework isn’t a “bad thing.”
“I don’t think we could ever get to a point where there is one best framework that answers all questions for all stakeholders,” she said.
To read the Society for Women’s Health Research’s article, click here.
Click here to read the NPC’s report, “Current Landscape: Value Assessment Frameworks.”
